Private Equity Fund IRRs Disclosed But Questions Linger
This article was originally published in Start Up
Executive Summary
Kicking and screaming, venture capital is being dragged into maturity. Demands are growing for greater disclosure in this secretive world. And with venture funds seeming to require more and more money, the VCs may not be able to resist the trend.
You may also be interested in...
Early-Stage Biopharma Investors Opt for Safer Bets in 2002
Discovery risk is for VCs like yesterday's newspaper. With the Big Pharma market for discovery tools abysmally quiet, early-stage funding for such firms saw a steep decline.
Early-Stage Biopharma Investors Opt for Safer Bets in 2002
Discovery risk is for VCs like yesterday's newspaper. With the Big Pharma market for discovery tools abysmally quiet, early-stage funding for such firms saw a steep decline.
Freedom of Information Litigation Puts the Spotlight on Valuation Practices
VC concern over efforts to compel public pension funds to disclose information regarding their private equity partners has largely focused on the release of internal rate of return statistics. A recent court ruling, however, suggests that the legal grounds for protecting the confidentiality of such data are tenuous at best. The more significant question is whether public pension funds can be forced to disclose their venture fund investees' valuations of individual portfolio companies. Public dissemination of that information would reveal the inconsistent (and possibly arbitrary) methods use to value companies.